MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
Character Biosciences
Finance & Acquisition: Character Biosciences
Parents
Character Biosciences
Children
2024: Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
2025: Funding was co-led by new investors aMoon and Luma Group, with additional participation from Bausch + Lomb and Jefferson Life Sciences, alongside existing investors Innovation Endeavors, Catalio Capital Management, S32, and KdT Ventures.
Jumps
Key People: Character Biosciences
Organization & Developments: Character Biosciences